ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025

Is It Time to Revisit the Role of Interleukin-1 Inhibitors in Osteoarthritis?

Martin Brom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.